JP2025502442A5 - - Google Patents

Info

Publication number
JP2025502442A5
JP2025502442A5 JP2024543244A JP2024543244A JP2025502442A5 JP 2025502442 A5 JP2025502442 A5 JP 2025502442A5 JP 2024543244 A JP2024543244 A JP 2024543244A JP 2024543244 A JP2024543244 A JP 2024543244A JP 2025502442 A5 JP2025502442 A5 JP 2025502442A5
Authority
JP
Japan
Application number
JP2024543244A
Other languages
Japanese (ja)
Other versions
JP2025502442A (ja
JPWO2023139147A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/051177 external-priority patent/WO2023139147A1/en
Publication of JP2025502442A publication Critical patent/JP2025502442A/ja
Publication of JPWO2023139147A5 publication Critical patent/JPWO2023139147A5/ja
Publication of JP2025502442A5 publication Critical patent/JP2025502442A5/ja
Pending legal-status Critical Current

Links

JP2024543244A 2022-01-21 2023-01-19 Staphylococcus saprophyticusによって引き起こされる感染症の処置における使用のためのゲポチダシンおよびバンコマイシン Pending JP2025502442A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263301522P 2022-01-21 2022-01-21
US63/301,522 2022-01-21
PCT/EP2023/051177 WO2023139147A1 (en) 2022-01-21 2023-01-19 Gepotidacin and vancomycin for use in the treatment of an infection caused by staphylococcus saprophyticus

Publications (3)

Publication Number Publication Date
JP2025502442A JP2025502442A (ja) 2025-01-24
JPWO2023139147A5 JPWO2023139147A5 (https=) 2026-01-22
JP2025502442A5 true JP2025502442A5 (https=) 2026-01-22

Family

ID=85108785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024543244A Pending JP2025502442A (ja) 2022-01-21 2023-01-19 Staphylococcus saprophyticusによって引き起こされる感染症の処置における使用のためのゲポチダシンおよびバンコマイシン

Country Status (6)

Country Link
US (1) US20250099535A1 (https=)
EP (1) EP4465989A1 (https=)
JP (1) JP2025502442A (https=)
CN (1) CN118574619A (https=)
CA (1) CA3240991A1 (https=)
WO (1) WO2023139147A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA015821B1 (ru) 2007-04-20 2011-12-30 Глэксо Груп Лимитед Трициклические азотсодержащие соединения в качестве антибактериальных агентов
WO2020201833A1 (en) * 2019-04-03 2020-10-08 Glaxomithkline Intellectual Property Development Limited Gepotidacin for use in the treatment of bacterial urinary tract infections

Similar Documents

Publication Publication Date Title
BR102023008688A2 (https=)
BR102023005164A2 (https=)
JP2025502442A5 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
CN307045119S (https=)
CN307045698S (https=)
CN307050159S (https=)
CN307049537S (https=)
CN307049530S (https=)
CN307049523S (https=)
CN307047753S (https=)
CN307047694S (https=)
CN307047636S (https=)
CN307047365S (https=)
CN307046074S (https=)
CN307046000S (https=)
BY13142U (https=)
BY13176U (https=)
CN307045776S (https=)
BY23963C1 (https=)
CN307045460S (https=)
CN307045306S (https=)
BY13141U (https=)
BY13163U (https=)